Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Reports Weak Q3 Revenues, Surging Loss

NEW YORK, Oct. 31 - Lexicon Genetics yesterday reported a significant fall in total third-quarter revenue atop a strong jump in R&D spending and a surge in net loss.

 

Revenues for the period ended Sept. 30 were $8 million, compared with $13.5 million during the same quarter one year ago, Lexicon said .

 

R&D spending in the quarter increased to $19.8 million from $15 million one year ago.

 

As a result, net loss ballooned to $16.8 million, or $.32 per share, from $6.2 million, or $.12 per share, in the third quarter 2001, the company said.

 

Lexicon Genetics said it had roughly $119.6 million in cash and investments as of Sept. 30.

 

Click here for more information.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.